Socio-economic Determinants for Acceptance and Choice of Biological Treatment
NCT04369651 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 117
Last updated 2020-05-01
Summary
This was a cross-sectional study conducted at National center for rheumatic diseases, Nepal on SpA patient refractory to initial treatment with conventional anti rheumatic drugs. Patients taking TNFi (tumor necrosis factor inhibitor- adalimumab or etanercept) or tofacitinib were included. Baseline demographic, socio-economic, clinical data were recorded.
Conditions
- Spondyloarthritis
Sponsors & Collaborators
-
National Center for Rheumatic Diseases, Nepal
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-01
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
More Related Trials
-
Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University Hospital
NCT06601595 ·Status: NOT_YET_RECRUITING
-
To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.
NCT05576051 ·Status: COMPLETED
-
Assessment of Galectin-9 in Rheumatoid Arthritis and Its Correlation With Disease Activity
NCT05422313 ·Status: UNKNOWN
-
Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study
NCT02489760 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes
NCT01258738 ·Status: COMPLETED ·Phase: PHASE3
-
Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
NCT00796705 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
NCT03414502 ·Status: RECRUITING ·Phase: PHASE3
-
Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis
NCT00726804 ·Status: TERMINATED ·Phase: PHASE4
-
Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis
NCT00626275 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD
NCT05936970 ·Status: RECRUITING
-
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
NCT01357668 ·Status: ACTIVE_NOT_RECRUITING
-
Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study
NCT02687620 ·Status: UNKNOWN
-
Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis
NCT05046431 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.
NCT02590562 ·Status: COMPLETED
-
A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis
NCT01298531 ·Status: COMPLETED ·Phase: PHASE4
-
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
NCT01557322 ·Status: COMPLETED
-
Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis
NCT04507763 ·Status: COMPLETED
-
Brigham and Women's Rheumatoid Arthritis Sequential Study
NCT01793103 ·Status: ACTIVE_NOT_RECRUITING
-
Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)
NCT02094326 ·Status: COMPLETED
-
Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients
NCT00895050 ·Status: COMPLETED
-
Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease
NCT02742337 ·Status: UNKNOWN
-
Immunogenicity and Safety of Vaccinations in Immunocompromised Persons
NCT01947465 ·Status: COMPLETED
-
Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis
NCT04144101 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in Spain
NCT00881881 ·Status: COMPLETED
-
Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis
NCT00900796 ·Status: COMPLETED